"what could (should) be announced before the end of the year
- ev1 design freeze
- ev2 jv
- commercial deal consumer batteries 1
- commercial deal Wyon
- separator1 test results achieved
- non dilutionary funding
- further lifescience deals
- 1000 cycles reached at 80% efficency
- production facility testing completed
- tax rebate
- ultranode further development
- marketing communication specialist to be selected
- varta relationship"
it'd be safe to assume the consumer batteries company is Varta since they supply the air pod batteries. Could the face we've taken one of their senior employees jeopardize the relationship? we have a long history of burning bridges
The only thing gauranteed on your list is the R&D tax rebate.
If none of the other eventuate before the end of the year then the company would be wise to start putting together another CR before they have to do it at fire sale prices.
I'd rather see a CR at 1.5c than 1c
Sorry, but it'd seem the market agrees with me. All this potential and only 2c?. It really is stupid and I completely lay all blame on the board for failing to market AnteoX to the broader community
There's an old saying, too little, too late
Great that they've appointed a sales VIP and looking at a marketing person but really, both these roles should've been in place 2 or more years ago
How do you go from having 8 energy collaborators, to ZERO and then starting from scratch again?
Bad relationships can be repaired. You don't just throw them in the too hard basket
I'm not saying get the pitchforks out but where's the accountability? the past two years performance has been shocking
the board to even expect performance shares is a joke. Why don't they say, this year, the board have elected not to take the performance shares.
Align shareholder interests with those of the directors
- Forums
- ASX - By Stock
- why ADO is a multi multi bagger
"what could (should) be announced before the end of the year-...
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
-0.001(3.67%) |
Mkt cap ! $52.28M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.1¢ | $7.812K | 349.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 828094 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 1102151 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 828094 | 0.021 |
7 | 1691000 | 0.020 |
2 | 782500 | 0.019 |
7 | 2041613 | 0.018 |
5 | 1374748 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 1102151 | 4 |
0.023 | 22000 | 1 |
0.025 | 40000 | 1 |
0.026 | 76000 | 2 |
0.027 | 22000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online